Cargando…
Use of (18)F FDG PET and the short temporal response of Hodgkin's disease to RIT
Radioimmunotherapy (RIT) has been available for some time to treat patients with non-Hodgkin's lymphoma, but its use in Hodgkin's lymphoma has been less available, partly because of the need to find an appropriate antibody. A new radioiodinated chimeric antibody directed against the CD25 e...
Autores principales: | Nowosinska, Ewa, Chan, Pei San, Buscombe, John R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034536/ https://www.ncbi.nlm.nih.gov/pubmed/30034281 http://dx.doi.org/10.4103/wjnm.WJNM_50_17 |
Ejemplares similares
-
[(18)F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
por: Kanoun, Salim, et al.
Publicado: (2018) -
Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes
por: Zhou, Yeye, et al.
Publicado: (2021) -
Pediatric Hodgkin Lymphoma: Predictive value of interim (18)F-FDG PET/CT in therapy response assessment
por: Ferrari, Cristina, et al.
Publicado: (2017) -
Initial Staging of Hodgkin’s Disease: Role of Contrast-Enhanced (18)F FDG PET/CT
por: Chiaravalloti, Agostino, et al.
Publicado: (2014) -
Clinical Utility of (18)Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography ((18)F-FDG PET/CT) in Multivisceral Transplant Patients
por: Ong, Shao Jin, et al.
Publicado: (2023)